Document is current
Any future updates will be listed below
-
Authors
Lugin, Margaret L.
Lei, Winnie
Lee, Rebecca T.
Chung, Jee Young
Katritsis, Nicholas M.
Hwang, Woochang
Fleischman, Angela G.
Han, Namshik
Kwon, Young Jik https://orcid.org/0000-0003-4086-6995
-
Funding
Funding for this research was provided by:
National Cancer Institute (1R21CA228099-01A1)
National Cancer Institute (T32CA009054)
Naational Institute of Health (P30CA062203)
National Research Foundation of Korea (RS-2025-18362970)
Ministry of Science and ICT, South Korea (RS-2025-25427881)
- License Information
-
More Information
Article History
Received: 13 February 2026
Accepted: 26 March 2026
First Online: 13 April 2026
Declarations
:
: Y.J.K. is a co-founder of Match the Hatch Biotechnology, Inc. and a consultant to PharmaResearch, Co., Ltd. N.H. is a cofounder and Chief Technology Officer of CardiaTec Bio, and a cofounder of KURE.ai. N.H. receives research funding from and collaborates with LifeArc, and has served as a consultant for DNA Link Ltd. None of these activities are directly relevant to the reported study. W.L. is currently employed by Avatrial Ltd., which works in the field of cancer therapeutics. This role began after completion of the research reported here.
